| Fri, Nov 27, 2009 | | • | Biotech Bargains for Your Portfolio
at Motley Fool (Fri, Nov 27)
| | • | 4-Star Stocks Poised to Pop: Cytori Therapeutics
at Motley Fool (Fri, Nov 27)
| | Wed, Nov 25, 2009 | | • | Exelixis Announces December 1 Webcast of Presentation at Piper Jaffray's 21st Annual Healthcare Conference
Business Wire (Wed, Nov 25)
| | Tue, Nov 24, 2009 | | • | Exelixis Announces Webcast of Its Fifth Annual R&D Day on December 2
Business Wire (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | • | Icahn Makes Big Moves in Healthcare Stocks
Indie Research (Mon, Nov 23)
| | Wed, Nov 18, 2009 | | • | Four Healthcare Stocks On Fire
at Investopedia (Wed, Nov 18)
| | • | 9 Things You Should Do Instead of Buying Stocks
at Motley Fool (Wed, Nov 18)
| | • | Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor Xl147 (SAR245408) in Combination with Erlotinib at the AACR-NCI-EORTC Conference
Business Wire (Wed, Nov 18)
| | • | Early-Market Movers:Vivus, Exelixis
at Fox Business (Wed, Nov 18)
| | • | Exelixis downgraded by Merriman
Briefing.com (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | Exelixis Reports Encouraging Phase 1 Data for the PI3K Inhibitor XL147 (SAR245408) in Combination with Paclitaxel and Carboplatin at the AACR-NCI-EORTC Conference
Business Wire (Tue, Nov 17)
| | • | Cramer's Stop Trading! Why Is Boeing Flying? (11/16/09)
at Seeking Alpha (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | Cramer: Retail Investors Returning to Market?
at CNBC (Mon, Nov 16)
| | Fri, Nov 13, 2009 | | • | Exelixis Announces November 18 Webcast of Presentation at Lazard's 6th Annual Healthcare Conference
Business Wire (Fri, Nov 13)
| | Thu, Nov 12, 2009 | | • | 3 Stocks Hitting High Notes
at Motley Fool (Thu, Nov 12)
| | • | 5-Star Stocks Poised to Pop: Infinera
at Motley Fool (Thu, Nov 12)
| | Wed, Nov 11, 2009 | | • | Now That's What I Call a Drug Deal
at Motley Fool (Wed, Nov 11)
| | Mon, Nov 9, 2009 | | • | Cramer's 'Mad Money' Follow-Up: Nov. 9
at TheStreet.com (Mon, Nov 9)
| | Sun, Nov 8, 2009 | | • | Cramer's Mad Money - Earnings and IPOs to Watch (11/6/09)
at Seeking Alpha (Sun, Nov 8)
| | Fri, Nov 6, 2009 | | • | No Product Revenues, Plenty of Risk: Buy Exelixis?
at CNBC (Fri, Nov 6)
|
Add EXEL News to My Yahoo!:
 
| |
|
0.22% Nasdaq 
Headlines
